FDA blocks COVID‑19 and shingles vaccine safety papers
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- FDA blocked the publication of several vaccine safety studies after deeming the authors’ conclusions too broad.
- Andrew Nixon said the studies were withdrawn because the conclusions were not supported by the data, and the FDA acted to protect scientific integrity.
- New York Times reported a study of 7.5 million Medicare beneficiaries over 65 found anaphylaxis at roughly one per million Pfizer recipients and no other statistically significant risks.
- Angela Rasmussen confirmed the journal Vaccine withdrew a paper on 4.2 million vaccine recipients that noted rare fever‑related seizures and myocarditis.
- Janet Woodcock warned that the FDA is suppressing data that affirms vaccine safety, suggesting a pattern of non‑scientific rationales.
Why it matters: Taxpayers lose the benefit of several million dollars of research now hidden; the FDA retains control over vaccine safety narratives; the public loses timely safety data, which erodes confidence in immunizations.
